vTv Therapeutics, Inc. (VTVT)
33.89
+0.64
(+1.91%)
USD |
NASDAQ |
Aug 24, 16:00
33.61
-0.28
(-0.83%)
After-Hours: 20:00
vTv Therapeutics Market Cap : 133.49M for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 133.49M |
| August 21, 2026 | 130.98M |
| August 20, 2026 | 130.30M |
| August 19, 2026 | 129.57M |
| August 18, 2026 | 123.99M |
| August 17, 2026 | 123.32M |
| August 14, 2026 | 118.64M |
| August 13, 2026 | 121.51M |
| August 12, 2026 | 125.18M |
| August 11, 2026 | 130.14M |
| August 10, 2026 | 135.06M |
| August 07, 2026 | 139.32M |
| August 06, 2026 | 136.32M |
| August 05, 2026 | 135.46M |
| August 04, 2026 | 126.28M |
| August 03, 2026 | 127.57M |
| July 31, 2026 | 127.42M |
| July 30, 2026 | 128.72M |
| July 29, 2026 | 123.99M |
| July 28, 2026 | 122.41M |
| July 27, 2026 | 122.18M |
| July 24, 2026 | 121.04M |
| July 23, 2026 | 124.70M |
| July 22, 2026 | 124.74M |
| July 21, 2026 | 129.62M |
| Date | Value |
|---|---|
| July 20, 2026 | 127.54M |
| July 17, 2026 | 129.50M |
| July 16, 2026 | 127.18M |
| July 15, 2026 | 128.76M |
| July 14, 2026 | 125.57M |
| July 13, 2026 | 124.38M |
| July 10, 2026 | 131.91M |
| July 09, 2026 | 131.71M |
| July 08, 2026 | 136.40M |
| July 07, 2026 | 134.39M |
| July 06, 2026 | 136.04M |
| July 02, 2026 | 139.43M |
| July 01, 2026 | 138.05M |
| June 30, 2026 | 148.29M |
| June 29, 2026 | 142.86M |
| June 26, 2026 | 138.17M |
| June 25, 2026 | 145.02M |
| June 24, 2026 | 140.77M |
| June 23, 2026 | 139.13M |
| June 22, 2026 | 133.60M |
| June 18, 2026 | 138.01M |
| June 17, 2026 | 133.60M |
| June 16, 2026 | 126.98M |
| June 15, 2026 | 132.10M |
| June 12, 2026 | 129.05M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Spyre Therapeutics, Inc. | 9.392B |
| ACADIA Pharmaceuticals, Inc. | 5.104B |
| Alnylam Pharmaceuticals, Inc. | 31.56B |
| Anika Therapeutics, Inc. | 285.59M |
| Savara, Inc. | 1.142B |
Market Cap Related Metrics
| PS Ratio | 10.93 |
| Price to Book Value | 1.698 |
| Price | 33.89 |
| Earnings Yield | -3.12% |